omniture

3SBio Inc. Announces Filing of Annual Report on Form 20-F

2007-07-02 21:56 870


SHENYANG, China, July 2 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has filed with the SEC an annual report on Form 20-F for the year ended December 31, 2006. Copies of the report are available for download under the Investors page on the Company’s website at http://bbs.3sbio.com/en/News/ShowInfo_n16.aspx?ID=30 .

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at http://www.3sbio.com .

For more information, please contact

Investor Contact:

Clara Mak, CFO

3SBio Inc.

Tel: +86-24-2581-1820

Email: ir@3sbio.com

Investor Relations (HK):

Ruby Yim

Taylor Rafferty

Tel: +852-3196-3712

Email: 3sbio@taylor-rafferty.com

Investor Relations (US):

Mahmoud Siddig

Taylor Rafferty

Tel: +1-212-889-4350

Email: 3sbio@taylor-rafferty.com

Media Contact:

John Dooley

Taylor Rafferty

Tel: +1-212-889-4350

Email: 3sbio@taylor-rafferty.com

Source: 3SBio Inc.
Related Stocks:
NASDAQ:SSRX
collection